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Oxidative stress always accompany patients with metabolic syndrome (MS). Several researchers reported that 
soy-protein is able to decrease oxidative stress level. However, there is no report so far about soy-germ protein in 
relation to its potential to the decrease oxidative stress level of MS patients. The aim of this study was to explore the 
potential of soy-germ protein on activity of catalase enzyme in blood’s plasma as well as erythrocytes of MS patients. 
Double-blind randomized clinical trial was used as an experimental study. Thirty respondents were included in this 
study with MS, normal level blood sugar, low-HDL cholesterol but high in triglyceride, 40-65 years old, Body Mass 
Index > 25 kg/m2, live in Purwokerto and agreed to sign the informed consent. They were randomly grouped into 
3 different groups, 10 each: Group I, was given special milk that contains soy-germ protein and Zn; Group II, soy-
germ protein, while Group III was placebo; for two consecutive months. Data were taken from blood samples in 3 
different periods i.e. 0, 1, and 2 months after treatment. Two months after treatment, there was an increase from 
5.36 to 20.17 IU/mg (P = 0.028) in activity of catalase enzyme in blood’s plasma respondents who consumed milk 
containing soy-germ protein with or without Zn. A similar trend of catalase activity, but at a lower level, was also 
noticed in erythrocyte; which increased from 88.31 to 201.11 IU/mg (P = 0.013). The increase in activity of catalase 
enzyme in blood’s plasma was 2.2 times higher than that in erythrocytes.
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INTRODUCTION
 Metabolic syndrome (MS) which specifically 
characterized by obesity has always two or more 
risk factors such as type-2 diabetes mellitus, 
hypertriglyceridemia, low level of HDL, and high 
blood pressure. Factually, there is a strong relationship 
between obesity and high possibility of oxidative 
stress as well as degree of inflammation (Festa et al. 
2001; Keaney et al. 2003). This is possible because 
in a condition of obesity there will be an increase in 
glucose transport to adipose tissues. Endothelium 
cells in this tissue will then speed up the increase of 
glucose uptake through glucose transporter, so there 
will a hyperglicemic situation in the blood leads to 
the increase in NADPH oxidase and production of 
mitochondrial reactive oxygen species (ROS). A 
further effect of this situation is a condition called 
oxidative stress that activate inflammation signal. 
The activated-endothelium cells will then pull pro-
inflammation macrophage (Noronha et al. 2005). 
Weisberg et al. (2003) stated that those infiltrated-
macrophage to adipose tissues are the main source 
of cytokinin inflammation. Infiltrated-macrophage to 
the adipose tissues will also contribute to the increase 
of NADPH oxidase activity as well as production of 
ROS in that particular tissue.
 High level of oxidative stress can be seen from 
low activity of antioxidant enzymes like catalase. 
Recently, Winarsi et al. (2011) reported that activity 
of catalase enzyme within the metabolic syndrome 
patients was 6.42 UI/mg protein. This number was 
lower than that noted from healthy people at the 
same age (Winarsi et al. 2013). A similar trend was 
noted from activity of SOD enzyme, indicated that 
these patients were low in status of Zn component 
in their blood (Winarsi et al. 2011). This situation 
will contribute to the progressivity of atherosclerosis 
(Toshima et al. 2000; Libby et al. 2002; Noronha 
et al. 2005) and gradually metabolic syndrome will 
develop into vascular disease. Therefore, activity of 
catalase enzyme must be increased both intracellular 
and extracellular.
 Some researchers reported that protein of soy 
bean seeds is potentially used as an antioxidant 
source (Hermansen et al. 2001; Bazzolia et al. 2002; 
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Winarsi et al. 2005). Especially when the seeds are 
germinated, because it contains more isoflavone than 
that of natural seeds (Winarsi et al. 2010; Song et 
al. 2003). In this situation, antioxidative character 
of soy-germ protein toward diabetes mellitus type 
2 patient was stronger than that of protein from soy 
bean seeds (Winarsi et al. 2009).  However, there is 
no report of the potential of soy-germ protein on the 
activity of catalase enzyme in metabolic syndrome 
patients. This study aimed to explore the potential of 
soy-germ protein on the activity of catalase enzyme in 
the blood’s plasma and erythrocytes of the metabolic 
syndrome patients.
MATERIALS AND METHODS
 This study was a continuation of Winarsi et al. 
(2012) which used double-blind randomized clinical 
trial for two consecutive months. Total respondents of 
this study were 30 women with metabolic syndrome. 
A preliminary survey was done in the polyclinic of 
internal disease of the Margono Soekarjo Hospital, 
Purwokerto, to select respondents. All respondent 
candidates were then visited at their home and 
received motivation and explanation about their 
disease and its development. Respondent’s criteria 
were as follows: sugar blood content was higher than 
normal  (fasting > 100 mg/dL; 2 h postprandial > 126 
mg/dL; anytime > 200 mg/dL), hypertriglyceridemia 
(>150 mg/dL), low-HDL cholesterol (<50 mg/dL), 
age between 40 to 65 years old, Body Mass Index 
(BMI) > 25 kg/m2 (Table 1), live in Purwokerto, and 
agreed to sign informed consent. Respondents were 
then divided into 3 (three) different groups, each 
group consist of 10 patients. Group I, was given 
functional milk which based on soy-germ protein 
plus Zn; group II, was given functional milk which 
based on soy-germ protein without Zn; and group III 
was given placebo milk (Table 2); each group was 
treated for two consecutive months.
 Blood sampling was taken 3 times as in a 
baseline phase, 1 and 2 months after treatment; for 
this purpose sample was taken intravenously at the 
amount of 2 mL using a venoject tube with EDTA. 
In order to measure the activity of catalase enzyme, 
blood sample was then separated from its plasma 
and erythrocyte. Activity of catalase enzyme in 
the erythrocyte was done using the upper layer of 
erythrocyte solution after grounded and centrifuged 
to split the solution into two different layers.
 Measurement of Catalase Enzyme Activity in 
Plasma or Erythrocyte. Lysate was initially prepared 
by addition of 800 µL 0.5% Triton X-100 solution 
into 200 µL blood’s plasma/erythrocyte. Following 
to this was preparation of a standard solution that 
would be  used to measure all samples. Stock solution 
was prepared by diluting 10 µL catalase in 50 mL of 
phosphate buffer. A standard solution was made from 
0.5 mL of stock solution into 9.5 mL of phosphate 
buffer (1/20) and 0.5 mL stock solution into 19.5 
mL phosphate buffer (1/40). Ten µL of lysate was 
then  fixed with 12.5 mL phospate buffer. A chemical 
reaction will be started after addition of 1 mL H2O2. 
All solutions were then mixed using vortex at slow 
motion, then placed in a spectrophotometer at 240 
nm wavelength at the interval of 15, 30, 45, and 60 
sec for measuring any change in absorbance. The A240 
value ranged from 0.02-0.10 (Winarsi et al. 2006).
Calculation:A30s - A60s measurement  x 87.44*
A30s – A60s standard 1/20
Table 1. Respondent’s profile in a baseline
I II III P =
Age (year)
BMI (kg/m2)
Blood’s glucose (mg/dL)
Triglyseride (mg/dL)
HDL (mg/dL)
Blood’s pressure, Sistole (mmHg)
Blood’s pressure, Diastole (mmHg)
50.2 + 2.0
31.09 + 1.1
221.2 + 15.36
236.4 + 37.9
45.19 + 3
156 + 9
106 + 2
51.5 + 2.3
31.23 + 0.7
213.7 + 6.8
204 + 22.8
48.73 + 2
149 + 8
108 + 7
49.5 + 2.3
33.33 + 0.99
223.3 + 8.83
212 + 30.4
45.87 + 2.3
154 + 6
102 + 4
0.81
0.21
0.81
0.74
0.61
0.81
0.71
I = group that was given soy-germ protein + Zn; II = Group that was given soy-germ protein without Zn; C = placebo. Data were 
shown as mean + Standard error; n = 10 (Winarsi et al. 2012).
Table 2. Chemical composition of the products given to the 
respondents
(%) A B C
Water
Ash
Fat
Protein
Carbohydrate
Total
4.79 + 0.08
22.68 + 0.07
1.11 + 0.01
42 + 0.05
29.39 + 0.04
100 + 0.005
4.6 + 0.008
22.57 + 0.09
1.02 + 0.003
39.47 + 0.09
32.27 + 0.02
100 + 0.003
4.5 + 0.003
22.4 + 0.006
1.04 + 0.003
36.72 + 0.037
35.03 + 0.32
100 + 0.03
A: functional milk based on soy-germ protein +Zn; B: 
functional milk based on soy-germ protein without Zn; C: 
placebo. Data were shown as an average values with +Standard 
Error, 3 replications (Winarsi et al. 2012).
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87.44 = a conversion factor, titration of catalase 
according to the recipe 13.99 x 10-3 UI/mL x dilution 
factor (1/6250).
RESULTS
 Catalase Activity of Blood’s Plasma. At the 
baseline phase, catalase activity of blood’s plasma 
of women with metabolic syndrome was 5.29 IU/
mg in average. This level did not differ among these 
respondents of the groups (P = 0.83). A similar 
condition was noted for all respondents after being 
tretaed for 1 month (P = 0.25). However, a significant 
increase was noted after the respondents were treated 
for 2 months, i.e. 20.17 IU/mg (P = 0.018). This high 
level of catalase enzyme activity was particularly 
noted when respondents consumed milk based on 
soy-germ protein plus Zn and a similar trend was 
also noted from group which taken milk based on 
soy-germ protein without addition of Zn (P = 0.47) 
(Figure 1). It can be concluded that addition of Zn 
compound did not increase the activity of catalase 
enzyme in human’s blood plasma.
 Catalase Activity of Erythrocyte. At a baseline, 
it was noted that activity of catalase enzyme in the 
erythrocyte of women with metabolic syndrome was 
72.57 IU/mg. This level was similar among those 
selected respondents (P = 0.84). After being treated 
for a period of one consecutive month, there was a 
trend to increase but the different was not statistically 
significant (P = 0.12). However, after being treated for 
another one month, the activity of catalase enzyme 
in erythrocyte was significantly different from that at 
the baseline (from 88.31 to 201.11 IU/mg; P = 0.013) 
especially in the group which was treated with milk 
based on soy-germ protein plus Zn. A slight increase 
(88.31 to 166.14 IU/mg; P = 0.04) was noted from 
another group which consumed milk based of soy-
germ protein but without addition of Zn (Figure 2). 
However, the data of catalase enzyme in erythrocyte 
were not statistically different (P = 0.50), which 
means that addition of Zn had also no effect on the 
activity of catalase enzyme in erythrocyte of women 
with metabolic syndrome.
DISCUSSION
 Some researchers have reported that oxidative 
stress has a strong relationship with Body Mass 
Index (BMI) (Olusi 2002; Keaney et al. 2003), 
where higher value of BMI is followed by higher 
level of oxidative stress. This was also noted from 
all respondents of the current study which have a 
BMI of 31.88 kg/m2, where at this level of BMI, the 
activity of catalase enzyme is low. Mahadev et al. 
(2004) found NOX4 which plays a significant role in 
forming the H2O2 (a strong oxidizing agent) to easily 
transformed into ROS within the adipose cells of 
obese patients. Therefore, higher BMI level might 
existed with higher NOX4 level and H2O2 compound 
being formed.
 It was noted in the current study that soy-germ 
protein was able to increase the activity of catalase 
enzyme in both blood’s plasma and erythrocyte. 
Winarsi et al. (2010) reported that soy-germ protein 
contains isoflavone (glicytein) which is higher than 
that of protein of soy seeds. Hubert et al. (2005) stated 
that glicytein has the largest potential of being used as 
a radical scavenger compared with other isoflavones, 
and this may contribute to lower H2O2 level at the 
preliminary phase and therefore, this compound will 
never be transformed into hydroxyl radical. This will 
lead to a lighter task of catalase enzyme because there 
is no radical to be cleared in the blood.
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Figure 1. Effect of soy germ protein on catalase activity of 
plasma of metabolic syndrome women. 
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Figure 2. Effect of soy germ protein on catalase activity of erythrocyte metabolic 
syndrome patient. 
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Figure 2. Effect of soy germ protein on catalase activity of 
erythrocyte of metabolic syndrome women. 
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 Lu et al. (2008) also reported that isoflavone 
in soy-germ could increase the glutation level in 
male Sprague-Dawley mice. Glutation, a tripeptide 
consists of amino acids cystein, glycine, and glutamic 
acid, is an antioxidant that participates directly in a 
process of neutralizing free radicals or ROS while 
keeping exogenous antioxidant in a good form. 
Furthermore, glutation was also noted to participate 
in detoxification of various xenobiotic both organic 
and inorganic through a step called direct conjugation. 
By optimalizing function of macrophage in balancing 
oxidative degeneration, especially those related with 
expansion of monoclonal of lymphocyte, glutation 
is also an important component in human immune 
response. Glutation can also stabilize mitochondrion 
membrane to reduce apoptopsis in lymphocyte cells, 
and deficiency of glutation, therefore, can lead 
to a condition called hemodialysis and oxidative 
stress. However, an opposite situation existed, 
because it was noted that activity of catalase enzyme 
in erythrocyte was higher than it was predicted, that 
might be related with an increase of glutation level. 
Beside isoflavone, peptides which were formed as 
a result of soy protein hydrolysis along germination 
period might also affected activity of catalase 
enzyme. Dia et al. (2009) observed five healthy men 
at the age of 18-25 years old, who were treated with 
50 g of soy protein in their daily intake. At the fifth 
day, respondents were checked for lunasin peptide 
content in their blood’s plasma, at 30 min and 1 h 
after consuming their daily diet, and data showed that 
there was an increase of lunasin peptide from 66.0 
+ 25.4 to 71.0 + 32.8 ng/mL. Several researchers 
stated that lunasin peptide could help to promote 
health status. Hernández-Ledesma et al. (2009) 
reported that lunasin peptide is able to suppress the 
level of oxidative stress through blocking of activity 
in oxidation of linoleic acid and radical scavenger 
2,2’-azinobis (3-ethylbenzothiazoline-6-asam 
sulfonat) (ABTS). Lunasin peptide was also noted to 
be able to suppress the release of pro-inflammation 
of TNF-α cytokin (tumor necrosis factor-α) and 
interleukine-6. Galvez et al. (2000) stated that in an 
exogenous application of lunasin, this compound 
could suppress transformation of fibroblast cells in 
mice that were deliberately induced by a carcinogenic 
material. Lunasin was also selectively induced 
apoptosis especially to those transforming cells, 
by blocking anacetylation of histon. This findings 
proved that the lunasin has an anti-inflammation 
and anti cancer characters, because of its strong 
antioxidant property. Based on this finding, lunasin 
might be contribute to the increase of catalase enzyme 
activity in both the blood’s plasma and erythrocytes 
of metabolic syndrome patients.
 In a general, amino acids with base, acids, or 
neutral character do not show its capacity as an 
antioxidant component. However, tryptophan, 
tyrosine, cysteine and homocysteine are also having 
antioxidant capacity in physiological concentration 
(Meucci and Mele 1995). An increase of activity 
of catalase enzyme might be also supported by the 
role of such amino acids contained in the soy-germ 
protein, as it was reported by Krajckovikova-
Kudlakcova et al. (2002).
 Along the process of soy seed germination, there 
is protein degradation to become free amino acids. 
Apart from isoflavone content level, increasing 
activity of catalase enzyme is also related with the 
availability of free amino acids in the soy-germ 
protein. Amino acids is the main component of 
all cells to do protein synthesis including catalase 
protein. As stated by Higashi and Shibata (1964), 
catalase enzyme consisted of 19 different amino 
acids, and most of them are available in the soy-germ 
protein. Higher protein for enzyme being produced 
would therefore increase activity of that particular 
enzyme.
 According to Atmaca (2004) sulphur is an 
important component for human body because it 
plays an important role in amino acids, protein and 
other bio-molecules formation. Sulphur is also an 
important component for flavoenzyme that contains 
Fe, for example catalase. Although most of nuts do 
not contain or contain low sulphur amino acids like 
methionine and cysteine, but these two amino acids 
are higher in soy than that of other nuts. In this case, 
catalase enzyme might be affected by the content of 
methionine and cysteine in the soy-germ protein to 
increase its activity.
 Potential of soy-germ protein as an antioxidant is 
mainly due to its own components like isoflavone, 
peptide and several amino acids. In this study, data 
showed that activity of catalase enzyme in either 
blood’s plasma or erythrocyte increased, though 
the level of increment in blood’s plasma was higher 
than that of in erythrocyte. It might be because of 
this enzyme has an intracellular character, therefore 
its activity in erythrocyte is higher than that of 
extracellular, though the increase in erythrocyte only 
12.7% in compared with 27.3% in blood’s plasma.
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